Skip to main content
Premium Trial:

Request an Annual Quote

Sigma-Aldrich Facilities Gain ISO Certification

NEW YORK (GenomeWeb) – Sigma-Aldrich today said that two of its St. Louis facilities have received ISO 13485 certification for expanded quality assurance capabilities. 

The certification extends the firm's ability to manufacture and offer raw materials including proteins, enzymes, and antibodies used in diagnostic assays, Sigma-Aldrich said. With the certification, its in vitro diagnostic customers can also be assured that their supply chain needs will be met, the firm said. 

Sigma-Aldrich's Dekalb site manufactures proteins and enzymes and received ISO 13485 certification after an investment into its production and packaging capabilities, as well as personnel training. Meanwhile, its facility in Barton can now serve as a central North American distribution center for the company's raw materials designed for IVD manufacturing applications. 

Sigma-Aldrich is in the process of being acquired by Merck KGaA for $17 billion. The firms have said that they aim to close the deal by mid-2015.

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.